MARATTO

article · OALib

Sociodemographic, Clinical and Therapeutic Characteristics of Serodiscordant Couples for the Human Immunodeficiency Virus Followed in Kinshasa: A Case of CH Monkole and Saint Anne Health Center

20232 citationsOpen accessUniversité de Kinshasa (UNIKIN)

Abstract

Background: The transmission of the Human Immunodeficiency Virus (HIV) during heterosexual intercourse is one of the leading modes of transmission at the origin of the global epidemic of HIV infection.Studies have indeed shown that in Sub-Saharan Africa, most women infected today are infected by their spouses, in the context of marital sexual relations.Objective: The objective of this study was to describe the sociodemographic, clinical and therapeutic characteristics of HIV serodiscordant couples in Kinshasa.Methods: This study is a cross-sectional descriptive study of HIV serodiscordant couples followed in Kinshasa.Data on socio-demographic, clinical and therapeutic characteristics were collected from a questionnaire during couples' interviews.Results: 17 serodiscordant couples were included in the study.The average time spent as a couple was 8.6 1.8 years.71.4% of HIV-positive partners were in the age group between 36 and 45 years.According to the BMI, 35.2% of HIV-positive people have normal weight, 11.7% are overweight and 2.9% are thin.47% of serodiscordant couples had intercourse 4 to 10 times, 41.7% had 1 to 3 times and 11.7% had more than 10 times per month.For the duration of ARV

Research topics

  • HIV/AIDS Research and Interventions
  • HIV/AIDS Impact and Responses

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.4236/oalib.1109678

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.